Recruiting ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma NCT07098364 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
